combination drug
Scope
Date
~
-
Retail
Korea's Lotte Mart and Lotte Super combine product sourcing
South Korea's Lotte Mart and Lotte Super will break away from the formats of hyper- and supermarkets and jointly raise the competitiveness of grocer...
Nov 10, 2022 (Gmt+09:00)
-
Economy
S.Korea to launch control tower for immigration policy
South Korea is set to establish a government body as early as the first half of 2023 to comprehensively control its immigration policy as Asia&rsquo...
Nov 08, 2022 (Gmt+09:00)
-
Bio & Pharma
No more ineffective drugs due to resistance
L-Base is a pharmaceutical startup specializing in developing drugs for those who become resistant to existing cancer treatments. This year, the Minis...
Nov 01, 2022 (Gmt+09:00)
-
Bio & Pharma
Moderna to stay ahead in mRNA technology: CSO Melissa Moore
CAMBRIDGE, MA – The COVID-19 coronavirus disease has been a curse for many people and companies around the world over the past couple of years...
Oct 14, 2022 (Gmt+09:00)
-
Bio & Pharma
SillaJen shares jump as exchange maintains listing, allows resumed trade
Shares in South Korea’s scandal-hit biotechnological company SillaJen Inc. soared on Thursday after the local exchange decided to maintain the...
Oct 13, 2022 (Gmt+09:00)
-
Energy
Only 3 Korean energy companies make it on 2022 Fortune Global 500 list
SK Inc., KEPCO Co. and GS Caltex Corp. are the only South Korean firms among the 77 energy companies listed on the 2022 Fortune Global 500, based on...
Sep 20, 2022 (Gmt+09:00)
-
Bio & Pharma
Sanofi, Korean biotech Lemonex ink material transfer agreement
South Korean biotech Lemonex Inc. has signed a material transfer agreement (MTA) with global pharmaceutical giant Sanofi S.A. to use the Korean bi...
Sep 14, 2022 (Gmt+09:00)
-
Real estate
Singapore's GIC sees its Seoul-based properties' values rise
Singapore’s sovereign wealth fund GIC is seeing the two Seoul-based landmarks it owns, Gangnam Finance Center and Seoul Finance Center, bring ...
Sep 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum
South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...
Sep 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean bio firms look to pills, patches for people who fear needles
Getting shots of a drug or vaccine over a long period is not easy for many people.That's probably why global biopharmaceutical companies and biotech...
Aug 24, 2022 (Gmt+09:00)
-
Automobiles
Hyundai Motor to redirect its TaaS, AI functions to self-driving arm 42dot
Hyundai Motor Group will redirect the core functions of its Transportation-as-a-Service (TaaS) division and AIRS Company to its recently acquired se...
Aug 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare logs record-high Q2 revenue on back of Remsima
Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.’s global marketing affiliate, posted its record-high second-quar...
Aug 17, 2022 (Gmt+09:00)
-
Bio & Pharma
TiumBio inks licensing deal with China's Hansoh for endometriosis drug
South Korean biotech TiumBio Co. has signed a technology transfer agreement of its endometriosis and uterine myoma treatment candidate with China&rs...
Aug 10, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals signs epilepsy drug deal with Brazil’s Eurofarma
South Korea’s SK Biopharmaceuticals Co. has signed a deal to license out its technology for Cenobamate, an antiepileptic drug, to Brazil&rsquo...
Jul 15, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech firms fold COVID-19 therapeutics development businesses
A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...
Jul 04, 2022 (Gmt+09:00)
-
Bio & Pharma
1 in 4 biotech firms struggles with decreasing cash reserves
South Korea’s biotechnology firms – public and private alike – are facing increasingly negative financial conditions. T...
Jun 26, 2022 (Gmt+09:00)
-
Bio & Pharma
Pharma companies jump into $3 bn pet care market
South Korean pharmaceutical companies are jumping into the animal medicine and diagnostics market to target the rapidly growing pet care market, whi...
Jun 24, 2022 (Gmt+09:00)
-
Metaverse
VA Corp. to build Asia’s largest virtual studio with LG’s LED displays
VA Corp. (VAC), a South Korean visual effects production startup, is building Asia’s largest virtual studio complex equipped with super-large ...
May 27, 2022 (Gmt+09:00)
-
Petrochemicals
Lotte Chemical raises stake in Fine Chemical amid merger talk
South Korea’s Lotte Chemical Corp. has raised its stake in affiliate Lotte Fine Chemical Co. amid speculation that the two companies may merge...
May 15, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Bio & Pharma
HK inno.N receives sales permit for ulcer treatment in China
HK inno.N is expediting its global expansion with its latest drug K-Cab designed to treat peptic ulcers.The South Korean pharmaceutical company an...
Apr 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi stands out with own drugs as Korean rivals sell imports
South Korea’s Hanmi Pharmaceutical Co. generated sales of more than 1 trillion won ($812.3 million) from its own medicines last year on strong...
Apr 11, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Morgan Stanley PE closes first Korean buyout in 8 yrs
Morgan Stanley Private Equity has acquired a South Korean dietary supplements maker Life & Bio Co., in its first Korean buyout deal in eight yea...
Apr 06, 2022 (Gmt+09:00)
-
IPOs
Two SK Group arms unveil lower-than-expected IPO guidance
SK Shieldus Co. and One Store Co., two units of South Korea's SK Square Co., submitted their initial public offering applications on Thursday to rai...
Apr 01, 2022 (Gmt+09:00)
-
Corporate strategy
SK Chemicals to invest $1.6 bn in green, biopharmaceutical sectors
South Korea’s SK Chemicals plans to invest more than 2 trillion won ($1.6 billion) in eco-friendly material and biopharmaceutical businesses.T...
Mar 28, 2022 (Gmt+09:00)
language -
Private equity
Morgan Stanley to sell Jeonju Paper for around $803 mn
New York-based Morgan Stanley Private Equity is slated to sell its entire stake in Jeonju Paper Corp., South Korea's top newsprint producer, and its...
Mar 15, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea Hanmi to launch blockbuster hypertension drug in China
South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...
Mar 11, 2022 (Gmt+09:00)
language -
Upcoming IPOs
Korea’s Voronoi in talks with global firms on drug designs
South Korea’s biotechnology startup Voronoi Inc. is in talks with global biomedical companies on drug designs as it aims to expand the busines...
Mar 04, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Singapore approves Korean Air-Asiana combination
Singapore’s antitrust authority approved the integration of Korean Air Lines Co. and Asiana Airlines Inc., paving the way for South Korea&rsqu...
Feb 09, 2022 (Gmt+09:00)
-
Petrochemicals
Samsung Eng. enters Russia with €1 bn petchem plant deal
South Korea’s Samsung Engineering made inroads into Russia’s plant engineering and construction market with a 1 billion euro ($1.1 billi...
Feb 09, 2022 (Gmt+09:00)